Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The food supplement improved hair growth and strength in people with a certain type of hair loss and had no major side effects.

PCOS should be reclassified into two types based on hormone levels and symptoms.

Melatonin in a special emulsion can help treat hair loss more effectively.

Alopecia areata patients often have eczema, thyroid issues, vitamin-D deficiency, and anemia.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Nanocarriers show promise for improving skin drug delivery in treating skin conditions.

Nanocarriers improve skin disease treatment by targeting hair follicles effectively.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

Nanocarriers can improve antioxidant delivery to the skin but face safety and production challenges.

Common baldness is likely inherited through multiple genes, not just one.

Male pattern baldness is likely caused by multiple genes, not just 5α-reductase genes.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Studying rare genetic disorders can help us understand and treat common diseases better.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Nanotechnology can improve wound healing by enhancing treatments and dressings.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

Light-activated hyaluronic acid derivatives can enhance skin healing and regeneration.

Unmodified fullerene C60 promotes hair growth and may help treat hair loss.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Nanocarriers could improve hair loss treatments by delivering drugs directly to hair follicles.

More research is needed to understand and treat cicatricial alopecias.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.